Abortion Opponents’ Next Push
A series of recent legal battles has been about abortion pills—but also about the anti-abortion movement’s broader post-<em>Roe</em> strategy.
This is an edition of The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here.
On Friday evening, a federal judge in Texas ruled to block access to the abortion drug mifepristone; this afternoon, the Justice Department appealed the decision. This case is about more than abortion pills: It also signals a potential new strategy for anti-abortion activists across the country.
But first, here are four new stories from The Atlantic:
- The pornography paradox
- The problem with weather apps
- The ruling that threatens the future of libraries
- The three biggest misconceptions about Israel’s upheaval
Capturing the Courts
For those keeping up with the abortion fight in the FDA to preserve access to the medication in a suit filed by 17 states and Washington, D.C.
